Publications by authors named "David A Clump"

Claim this Profile
D
Detecting Extranodal Extension in HPV-Related Oropharyngeal Cancer via Machine Learning.
Maher Alabboodi, Bradford Dugan, Amani Kais, Noah Shaikh, David A Clump

Laryngoscope· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case for Caution in a New Era of Managing Patients with Locally Advanced Non-Small Cell Lung Cancer: Fatal Bronchial-Esophageal Fistula After Neoadjuvant Chemo-Immunotherapy Followed by Definitive Chemoradiation Therapy.
Kaitlyn Heintzelman, John C Knoth, Casey Mozingo, Adrienne Duckworth, Cody Kilar, David A Clump

Pract Radiat Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence and Machine Learning in Sexual Health and Dysfunction Across the Cancer Care Continuum: A Systematic Review.
Vivian Salama, Brandon M Godinich, Peyton M Lilly, Phillip M Pifer, Adrienne L Duckworth, David A Clump

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer.
Dan P Zandberg, Lazar Vujanovic, David A Clump, Brian P Isett, Hong Wang

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative stereotactic radiosurgery for cerebral metastases: safe, effective, and decreases steroid dependency.
Arka N Mallela, Uzoma K Iheagwara, David Fogg, Austin Anthony, Zachary C Gersey, David A Clump

J Neurosurg· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery.
Lisa A Kachnic, Kathryn Winter, Mohan Suntharalingam, David Ilson, André Konski, David A Clump

Qual Life Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papillomavirus circulating tumor DNA: a diagnostic tool in squamous cell carcinoma of unknown primary-a pilot study.
Amani Kais, Stell Patadji Santiago, Peng Cheng Han, David A Clump, William A Stokes

Front Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach to infectious disease control and radiotherapy risk management.
Naveed M Islam, Shada J Wadi-Ramahi, Ron Lalonde, Tanvir Baig, Maria diMayorca, David A Clump

Med Phys· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504.
Maura L Gillison, Robert L Ferris, Jonathan Harris, A Dimitrios Colevas, Loren K Mell, David A Clump

Int J Radiat Oncol Biol Phys· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life in Patients With Recurrent and Second Primary Head and Neck Cancer.
Vaibhav H Ramprasad, Jinhong Li, Karley Atchison, Dan P Zandberg, David A Clump

Otolaryngol Head Neck Surg· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with ductal carcinoma in situ (DCIS) treatment patterns and patient-reported outcomes across a large integrated health network.
Hayeon Kim, Hong Wang, Kathryn Demanelis, David A Clump, John A Vargo

Breast Cancer Res Treat· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial.
Eric J Sherman, Jonathan Harris, Keith C Bible, Ping Xia, Ronald A Ghossein, David A Clump

Lancet Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy.
Frank P Vendetti, Pinakin Pandya, David A Clump, Sandra Schamus-Haynes, Meysam Tavakoli

JCI Insight· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients.
Janielle K-A Taylor, Leila J Mady, Khalil Baddour, Uzoma K Iheagwara, Shuyan Zhai, David A Clump

World J Otorhinolaryngol Head Neck Surg· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent bioavailability, absorption-rate limited elimination, and tissue distribution of the ATR inhibitor BAY-1895344 (elimusertib) in mice.
Brian F Kiesel, Joshua J Deppas, Jianxia Guo, Robert A Parise, David A Clump

Cancer Chemother Pharmacol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis.
Steven Borson, Yongli Shuai, Barton F Branstetter, Marci Lee Nilsen, Marion A Hughes, David A Clump

Laryngoscope Investig Otolaryngol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Trismus With Quality of Life and Swallowing in Survivors of Head and Neck Cancer.
Zeyao Jia, Jinhong Li, Christine Harrison, Elizabeth Pawlowicz, David Anthony Clump

Otolaryngol Head Neck Surg· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer.
Robert L Ferris, Jessica Moskovitz, Sheryl Kunning, Ayana T Ruffin, Carly Reeder, David A Clump

Clin Cancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent bioavailability and tissue distribution of the ATR inhibitor AZD6738 (ceralasertib) in mice.
Brian F Kiesel, Jianxia Guo, Robert A Parise, Raman Venkataramanan, David A Clump

Cancer Chemother Pharmacol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life after radiation and transoral robotic surgery in advanced oropharyngeal cancer.
Thomas M Kaffenberger, Ankur K Patel, Lingyun Lyu, Jinhong Li, Tamara Wasserman-Wincko, David A Clump

Laryngoscope Investig Otolaryngol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Crowdfunding to Support Radiation Therapy Cancer Treatments.
Arpan V Prabhu, Milan Bimali, Mihailo Miljanic, Hannah Kay, Lyndsey Sandow, David A Clump

Anticancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer.
Julie E Bauman, Jonathan Harris, Ravindra Uppaluri, Min Yao, Robert L Ferris, David A Clump

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.
Jimm Grimm, John A Vargo, Panayiotis Mavroidis, Vitali Moiseenko, Bahman Emami, David A Clump

Int J Radiat Oncol Biol Phys· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term outcomes with linear accelerator stereotactic radiosurgery for treatment of jugulotympanic paragangliomas.
Ankur K Patel, Joshua L Rodríguez-López, Barry E Hirsch, Steven A Burton, John C Flickinger, David A Clump

Head Neck· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-response model for severe late laryngeal toxicity after stereotactic body radiation therapy for previously-irradiated head and neck cancer.
Diane C Ling, John A Vargo, Rachel J Grimm, Brian J Gebhardt, David A Clump

J Radiosurg SBRT· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis